Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- SMMT
- Price
- 17.37
- Stock movement up
- +0.44 (2.40%)
- Company name
- Summit Therapeutics PLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 14.00B
- Ent value
- 13.83B
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- 1.73%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2025-12-04
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
SMMT does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | -58866.19 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 744.44M |
| EPS (TTM) | -0.79 |
| FCF per share (TTM) | -0.40 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -15.01M |
| Operating income (TTM) | -600.89M |
| Net income (TTM) | -587.70M |
| EPS (TTM) | -0.79 |
| EPS (1y forward) | -0.75 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 238.55M |
| Net receivables | 0.00 |
| Total current assets | 246.47M |
| Goodwill | 2.00M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 6.23M |
| Total assets | 261.73M |
| Accounts payable | 22.25M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 64.93M |
| Total liabilities | 69.47M |
| Shareholder's equity | 192.26M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -297.94M |
| Capital expenditures (TTM) | 578.38K |
| Free cash flow (TTM) | -298.52M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -305.68% |
| Return on Assets | -224.55% |
| Return on Invested Capital | -305.68% |
| Cash Return on Invested Capital | -155.27% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 18.29 |
| Daily high | 18.98 |
| Daily low | 18.19 |
| Daily Volume | 2.73M |
| All-time high | 36.70 |
| 1y analyst estimate | 32.81 |
| Beta | -1.53 |
| EPS (TTM) | -0.79 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| SMMT | S&P500 | |
| Current price drop from All-time high | -52.67% | -0.89% |
| Highest price drop | -55.89% | -19.00% |
| Date of highest drop | 21 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -38.18% | -2.49% |
| Avg time to new high | 145 days | 6 days |
| Max time to new high | 156 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
14.00B
Marketcap category
Large-cap
Description
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.
Employees
159
Website
Investor relations
-
SEC filings
CEO
Glyn Owain Edwards
Country
USA
City
Abingdon
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page